[go: up one dir, main page]

Latest News for: hikma

Edit

Hikma champions healthcare resilience, MENA–China co-investment at World Economic Forum Annual Meeting of the New Champions

Al Bawaba 29 Jun 2026
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, concluded its participation at the World ...
Edit

Hikma Champions Healthcare Resilience and MENA – China Investment at WEF

Ammon 28 Jun 2026
Hikma Pharmaceuticals PLC (Hikma), the multinational ...
Edit

Behind Better Health: Hikma's People (Hikma Pharmaceuticals plc)

Public Technologies 23 Jun 2026
"When you join Hikma, you don't just join a company … you join a family.". Walid Khalifeh, who himself moved from Hikma's legal team into the role of Head of the US People function, said the welcome runs throughout.
Edit

Hikma welcomes FDA approval of Guardant360® Liquid CDx

Al Bawaba 23 Jun 2026
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, welcomes the recent U.S.
Edit

Key Takeaways on Induced Patent Infringement After Supreme Court Decision in Hikma v. Amarin (Baker, Donelson, Bearman, Caldwell & Berkowitz PC)

Public Technologies 23 Jun 2026
) In an opinion authored by Justice Jackson earlier this month, a unanimous Supreme Court recently reversed the Federal Circuit and held that Amarin Pharma, Inc ... Section 271(b) ... Disclaimer ... (noodl. 132635812) .
Edit

Hikma welcomes FDA approval of Guardant360® Liquid CDx (Hikma Pharmaceuticals plc)

Public Technologies 22 Jun 2026
London, 22 June 2026 - Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, welcomes the recent U.S ... Hikma signed an exclusive agreement with Guardant Health, Inc ... Hikma ...
Edit

2026 interim results pre-announcement aide memoire (Hikma Pharmaceuticals plc)

Public Technologies 16 Jun 2026
Hikma Pharmaceuticals plc published this content on June 16, 2026, and is ...
Edit

US Supreme Court Sides With Generic Drugmaker Hikma in ‘Skinny Label’ Patent Case

The Epoch Times 05 Jun 2026
Supreme Court on June 4 ruled that drugmaker Hikma Pharmaceuticals’ generic version of Amarin Pharma’s cardiovascular medication Vascepa did not infringe ...
Edit

The Skinny on the Supreme Court’s Decision in Patent Infringement Case Hikma v. Amarin (Greenberg Traurig LLP)

Public Technologies 05 Jun 2026
Supreme Court issued a unanimous opinion in Hikma Pharmaceuticals USA Inc ... Justice Jackson, writing for the Court, resolved a dispute over Hikma's generic version of Amarin's ...
Edit

U.S. Supreme Court Backs "Hikma" in Vascepa Patent Dispute

Petra 05 Jun 2026
Supreme Court has ruled that Hikma Pharmaceuticals’ generic version of the cardiovascular drug Vascepa does not infringe patents held by Amarin Pharma, in a landmark decision that could reduce the ...
Edit

Hikma Pharmaceuticals puts access to medicines at the heart of its sustainability strategy, reaching 222 million patient... (Hikma Pharmaceuticals plc)

Public Technologies 04 Jun 2026
London, 4 June 2026 - Hikma Pharmaceuticals PLC, today published its 2025 Sustainability Report - Acting Responsibly - reaffirming access to medicine as the cornerstone of its sustainability strategy and its leading sustainability pillar.
Edit

Hikma comments on Supreme Court of the United States’ unanimous decision in favour of Hikma (Hikma Pharmaceuticals plc)

Public Technologies 04 Jun 2026
London, 4 June 2026 - Hikma Pharmaceuticals PLC, along with its ... Amarin sued Hikma, wrongly alleging that Hikma was marketing the generic icosapent ethyl for both the patented and non-patented uses.
Edit

Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma

PR Newswire 04 Jun 2026
LONDON, June 4, 2026 /PRNewswire/ -- Hikma ... Amarin sued Hikma, wrongly alleging that Hikma was marketing the generic icosapent ethyl for both the patented and non-patented uses.
Edit

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (Supreme Court of the United States)

Public Technologies 04 Jun 2026
). The text version of this document is not available ... Attachments Permalink. Disclaimer.
Edit

Hikma launches Tofacitinib oral solution in the US (Hikma Pharmaceuticals plc)

Public Technologies 03 Jun 2026
London, 3 June 2026 - Hikma Pharmaceuticals PLC (Hikma, Group), a multinational pharmaceutical company, today announced the launch of Tofacitinib oral solution, 1 mg/mL, in a 240 mL bottle in the US ... About Hikma ... https.//www.hikma.com.

Article Search

tools
×
×
×
×